Ensysce Biosciences (ENSC) Misses Q2 EPS by 79c
Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.